Gastrointestinal bleeding. Gastrointestinal hemorrhage, unspecified
Conditions
Interventions
Intervention 1: Control group: 30 patients will be treated with standard gastrointestinal bleeding treatment and the first placebo of normal saline will be infused 100 cc in 20 minutes and then 100 cc
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All patients with a diagnosis of severe upper or lower gastrointestinal bleeding
Exclusion criteria
Exclusion criteria: Previous allergy to vasopressin or tranexamic acid coagulation disorders Suspected acute myocardial infarction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Gastrointestinal bleeding volume. Timepoint: During the first 24 hours after receiving the drug. Method of measurement: Using a Calibrated container or non-sterile gas (each blood gas completely impregnate with equivalent to 20 ml blood ). | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood pressure. Timepoint: Every 30 minutes to 24 hours after receiving the drug. Method of measurement: Automatic arm pressure gauge cuff.;Pulse rate. Timepoint: Every 30 minutes to 24 hours after receiving the drug. Method of measurement: Pulse oximeter device.;Patients venous hemoglobin concentration. Timepoint: When patients are admitted to the emergency room and then every 6 hours, up to 24 hours after receiving the drug. Method of measurement: Based on laboratory results by Cell counter device model H1. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSimin najafgholian
Arak University of Medical Sciences
Outcome results
None listed